| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1471-4159.2001.00006.X |
| P8608 | Fatcat ID | release_j3i2ldq2qbc7tlw5vmrzjzj7ku |
| P698 | PubMed publication ID | 11145976 |
| P5875 | ResearchGate publication ID | 247661544 |
| P2093 | author name string | H S Hansen | |
| H H Hansen | |||
| C Ikonomidou | |||
| S H Hansen | |||
| P Bittigau | |||
| P2860 | cites work | Formation and inactivation of endogenous cannabinoid anandamide in central neurons | Q29620558 |
| The changing landscape of ischaemic brain injury mechanisms. | Q33678157 | ||
| Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity | Q33695254 | ||
| Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices | Q33865224 | ||
| Excitotoxic cell death | Q34245367 | ||
| NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release | Q34289674 | ||
| The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons | Q34380089 | ||
| N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain | Q37190678 | ||
| N-acylated glycerophospholipids and their derivatives | Q37793330 | ||
| Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period | Q42475353 | ||
| Ionophore-induced apoptosis: role of DNA fragmentation and calcium fluxes | Q43459477 | ||
| N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain | Q44269681 | ||
| N-acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability to transphosphatidylate | Q48148574 | ||
| Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain | Q48192041 | ||
| Calcium ionophores can induce either apoptosis or necrosis in cultured cortical neurons | Q48203897 | ||
| Polyamines modulate the neurotoxic effects of NMDA in vivo | Q48249581 | ||
| Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain | Q48317594 | ||
| Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity. | Q48469785 | ||
| Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. | Q48942589 | ||
| Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh | Q48962059 | ||
| Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists. | Q53006176 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| anandamide | Q410228 | ||
| cannabinoids | Q422936 | ||
| P304 | page(s) | 39-46 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death | |
| P478 | volume | 76 |
| Q91106132 | A protective role for N-acylphosphatidylethanolamine phospholipase D in 6-OHDA-induced neurodegeneration |
| Q34995079 | Acute neuronal injury, excitotoxicity, and the endocannabinoid system |
| Q24681412 | Alzheimer's disease; taking the edge off with cannabinoids? |
| Q40182562 | Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine |
| Q40514538 | Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways. |
| Q47944859 | Binge Alcohol Exposure Transiently Changes the Endocannabinoid System: A Potential Target to Prevent Alcohol-Induced Neurodegeneration. |
| Q35166600 | Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases |
| Q44046073 | Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity. |
| Q44504754 | Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure |
| Q40672579 | Calcium influx through receptor-operated channel induces mitochondria-triggered paraptotic cell death. |
| Q43591890 | Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity. |
| Q36211444 | Cannabinoid receptors and their role in neuroprotection |
| Q38563981 | Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications |
| Q35035836 | Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges |
| Q58331887 | Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice |
| Q94563364 | Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice |
| Q57351148 | Endocannabinoids |
| Q37015432 | Endocannabinoids and reactive nitrogen and oxygen species in neuropathologies. |
| Q40794240 | Endocannabinoids and the processing of value-related signals |
| Q43792413 | Exogenous anandamide protects rat brain against acute neuronal injury in vivo. |
| Q64068768 | Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson's disease patients |
| Q24623244 | Hub and switches: endocannabinoid signalling in midbrain dopamine neurons |
| Q46423002 | Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. |
| Q44433428 | Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase |
| Q35752224 | Involvement of cannabinoid receptors in gut motility and visceral perception |
| Q34130227 | Involvement of ceramide in ethanol-induced apoptotic neurodegeneration in the neonatal mouse brain |
| Q34673425 | Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for stroke |
| Q28397015 | Mass spectrometry imaging of biomarker lipids for phagocytosis and signalling during focal cerebral ischaemia |
| Q41948547 | Miscibility and phase behavior of N-acylethanolamine/diacylphosphatidylethanolamine binary mixtures of matched acyl chainlengths (N=14, 16). |
| Q83143484 | Molecular packing and intermolecular interactions in two structural polymorphs of N-palmitoylethanolamine, a type 2 cannabinoid receptor agonist |
| Q28351436 | N-Acylphosphatidylethanolamine accumulation in potato cells upon energy shortage caused by anoxia or respiratory inhibitors |
| Q35625431 | Neuropathological and biochemical features of traumatic injury in the developing brain |
| Q36374839 | New horizons for newborn brain protection: enhancing endogenous neuroprotection |
| Q44283634 | Oleic acid content of a meal promotes oleoylethanolamide response and reduces subsequent energy intake in humans |
| Q46551717 | On the importance of anandamide structural features for its interactions with DPPC bilayers: effects on PLA2 activity |
| Q78727774 | Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects |
| Q30495206 | Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis |
| Q34786823 | Putative neuroprotective actions of N-acyl-ethanolamines |
| Q37105737 | Quantitative analysis of N-acylphosphatidylethanolamine molecular species in rat brain using solid-phase extraction combined with reversed-phase chromatography and tandem mass spectrometry |
| Q36967863 | Role of cannabinoids and endocannabinoids in cerebral ischemia |
| Q43962847 | Substantial species differences in relation to formation and degradation of N-acyl-ethanolamine phospholipids in heart tissue: an enzyme activity study |
| Q40877659 | Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats |
| Q37960078 | Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies. |
| Q44885320 | The "dark side" of endocannabinoids: a neurotoxic role for anandamide |
| Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
| Q45171657 | The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity |
Search more.